Table 2.
Levels of circulating ILC2, estradiol, and progesterone
| Non-pregnant | Early-pregnant | Late-pregnant | P value | |
|---|---|---|---|---|
| N | 25 | 25 | 25 | |
| ILC2 | ||||
| Percentage in ILCs, % | 36.40 (29.90, 46.90) | 55.80 (48.30, 57.50) | 77 (72.20, 79.10) | < 0.001*** |
| Percentage in CD45+ cells, % | 0.02 (0.02, 0.04) | 0.04 (0.03, 0.06) | 0.07 (0.05, 0.12) | < 0.001*** |
| Absolute count, per ml | 98.81 (64.02, 186.15) | 191.22 (113.02, 298.87) | 289.61 (229.21, 397.14) | < 0.001*** |
| Estradiol, pg/ml | 57.10 (34.16, 88.56) | 408.48 (297.93, 488.08) | 6362.75 (5534.62, 7410.15) | < 0.001*** |
| Progesterone, ng/ml | 4.61 (3.24, 10.22) | 13.77 (10.70, 21.26) | 164.37 (108.61, 214.33) | < 0.001*** |
Variables are shown as median (Q1, Q3). Comparisons of levels of circulating ILC2s, plasma estradiol, and progesterone among non-pregnant, early-pregnant, and late-pregnant women were assessed using Kruskal-Wallis tests. P-values less than 0.05 (P < 0.05) were considered significant. ***P < 0.001. Q1 the first quartile, Q3 the third quartile